SCHEMBL20074628

SCHEMBL20074628

CC(C)(C)OC(O)N1CC[C@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21549978 1.00 — —
SCHEMBL18972203 1.00 — —
SCHEMBL12346568 0.90 — —
SCHEMBL21363829 0.89 — —
SCHEMBL17177280 0.89 — —
SCHEMBL21567573 0.87 — —
SCHEMBL21795530 0.83 — —
SCHEMBL15184433 0.80 — —
SCHEMBL19574903 0.79 CYP2D6 (0.36) —
SCHEMBL23134752 0.78 GBA1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10259787-B2 Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists HEPTARES THERAPEUTICS LIMITED (GB) 2019-04-16 — — US disclosed
US-20180105491-A1 PHARMACEUTICAL COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2018-04-19 — — US disclosed
Send feedback